Abstract
Development of polymeric micelles for the management of allergic conjunctivitis to overcome the limitations of topical installation, such as poor patient compliance, poor stromal permeability, and significant adverse effects, increase precorneal residence time and efficacy, and also control the release of drug at the target site. The investigation was aimed at developing a polymeric micellar system of Azelastine HCl for Ocular Delivery. Drug loaded micelles of tri-block copolymers Pf 127 were prepared by Thin Film hydration method. The polymeric micelles formulations (F1 to F9) were assessed for entrapment efficiency, micelle size, in vitro permeation, ex vivo transcorneal permeation, in vivo Ocular Irritation, and Histology. Optimized micelles formulation (F3), with the lowest micelle size of 92 nm, least polydispersity value of 0.135, highest entrapment efficiency of 95.30 ± 0.17%, and a cumulative drug permeation of 84.12 ± 1.26% in 8h, was selected to develop pH-sensitive micelles loaded carbopol in situ gel. The optimized in situ gel (G4) proved to be superior in its ex vivo transcorneal permeation when compared with Market Preparation and pure drug suspension, exhibiting 43.35 ± 1.48% Permeation with zero-order kinetics (...Continue Reading
References
Nov 1, 1989·Drugs·D McTavish, E M Sorkin
Feb 1, 1988·The British Journal of Ophthalmology·M R Jain
Jan 1, 1996·Current Medical Research and Opinion·W LassigA Roloff
Jan 1, 1997·Current Medical Research and Opinion·G LenhardA Secchi
Aug 15, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander V KabanovValery Yu Alakhov
Jan 25, 2003·International Ophthalmology Clinics·Andrea Leonardi, Antonio G Secchi
Jun 30, 2004·Investigative Ophthalmology & Visual Science·Derya Gulsen, Anuj Chauhan
Feb 24, 2005·International Journal of Pharmaceutics·Derya Gulsen, Anuj Chauhan
Apr 26, 2005·International Journal of Pharmaceutics·Yan WuShoukuan Fu
Jun 2, 2007·Journal of Pharmaceutical Sciences·Anne DanionPatrick Vermette
Feb 16, 2008·Drug Discovery Today·Eva M Del Amo, Arto Urtti
Feb 16, 2008·Drug Discovery Today·Sanjeeb K SahooS Krishnakumar
Mar 14, 2008·Toxicologic Pathology·Brian G Short
Jun 26, 2008·International Journal of Pharmaceutics·Yash Kapoor, Anuj Chauhan
Jun 16, 2010·Drug Development and Industrial Pharmacy·H O AmmarA A Mahmoud
Jul 31, 2010·Immunology and Allergy Clinics of North America·Brett Bielory, Leonard Bielory
Dec 24, 2010·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Clyde SchultzDouglas Morck
Apr 9, 2011·Eye·E LavikY H Kwon
Jul 26, 2011·Current Opinion in Allergy and Clinical Immunology·Nelson Rosario, Leonard Bielory
Mar 2, 2012·Journal of Microencapsulation·Ujwala A ShindeKavita H Singh
Mar 2, 2012·Biomacromolecules·Xiaoyong ZhaoPaula T Hammond
Aug 7, 2013·International Journal of Pharmaceutics·Jing LiQunwei Xu
Apr 22, 2014·International Journal of Pharmaceutics·Yunbo SunXiaohong Qian
Apr 19, 2015·Colloids and Surfaces. B, Biointerfaces·Munmun JaiswalKamla Pathak
Jun 1, 2016·Journal of Liposome Research·Rawia M KhalilHadeer A El-Hashemy